27 genetic testing technology application demonstration centers were approved

[China Pharmaceutical Network Technology News] In recent years, the state has attached great importance to the genetic industry. During the "13th Five-Year Plan" period, the state has made the development of genetic technology the core task of innovation in the biomedical industry, an important measure for health and benefit, and an important part of the supply-side reform. . Recently, the National Development and Reform Commission issued the "Response on the Construction of the First Batch of Gene Detection Technology Application Demonstration Centers" (Development and Reform Office Gaoji [2016] No. 534), officially approved the construction of 27 genetic testing technology application demonstration centers. .

According to the website of Ningbo Health and Family Planning Commission on March 31, in March 2016, the construction project of Ningbo Genetic Testing Technology Application Demonstration Center was approved by the National Development and Reform Commission.

According to the website of the Sichuan Provincial Development and Reform Commission on April 5, the Sichuan Province Genetic Testing Technology Application Demonstration Center was included in the first batch of national application demonstrations.

According to the website of the Development and Reform Commission of Shandong Province on April 11, the construction plan of Shandong Province Genetic Testing Technology Application Demonstration Center was approved by the National Development and Reform Commission. The National Development and Reform Commission agreed to Shandong Province to build the “Shandong Province Genetic Testing Technology Application Demonstration Center”.

According to the General Hospital of Ning Medical University, the Ningxia Gene Detection Technology Application Demonstration Center has been approved by the National Development and Reform Commission. It is one of the first national demonstration centers for the application of genetic testing technology.

Promote genetic screening for genetic diseases such as Down's syndrome

The National Development and Reform Commission organized the construction of a genetic testing technology application demonstration center, aiming to vigorously develop genetic testing technology, and promote the application of genetic diseases to improve the birth defects, hereditary diseases, tumors, cardiovascular and cerebrovascular diseases, infectious diseases and other major diseases. The level of prevention and control will accelerate the development of China's bio-industry and health industry and comprehensively improve the quality of the population.

Ningbo Gene Detection Technology Application Demonstration Center will focus on building a genetic testing technology application demonstration center integrating scientific research, genetic testing, results evaluation, treatment guidance, data analysis and technical consultation, and carry out non-invasive prenatal screening and individualized cancer treatment. Medical services such as hereditary diseases, infectious diseases, cardiovascular diseases, endocrine diseases and personal genome testing. With the concept of health management, disease prevention as the guideline and high-throughput sequencing technology, the center will actively explore and construct the “Ningbo Gene Health Management System” to realize early diagnosis, early detection, early intervention and early treatment, and improve regional residents. The level of health management, after the completion of the annual specimen inspection capacity will reach 172,500 cases. The center is expected to open from June this year.

The Sichuan Provincial Demonstration Center adopts the “1 3 1” model construction, namely 1 comprehensive center, 3 sub-centers and 1 supporting center. The comprehensive center (built by Chengdu Boao Medical Laboratory) focuses on birth defects and genetic disease screening, and is responsible for coordinating overall coordination. The sub-center includes the Precision Medical Research Sub-center (constructed by Chengdu Huada Laboratory, jointly established by Huada Company and Huaxi Hospital), the Center for Oncology Prevention and Treatment (built by Chengdu New Gene Test Laboratory) and the High-throughput Sequencing Sub-center ( Built by Chengdu Berry and Kang Inspection Institute). The supporting center is the province's gene large database (constructed by Chengdu Chaoxiao Company) to realize a new mode of medical information and benefit service. After the completion of the demonstration center, genetic screening for genetic diseases such as Down's syndrome will be promoted throughout the province.

The Ningxia Gene Detection Technology Application Demonstration Center has completed the initial design plan and will start construction in June 2016. It is expected to be officially put into use in March 2018. The center is located in Ningxia Biotechnology Information Industrial Park, Yinchuan Comprehensive Bonded Zone, with a construction area of ​​16,218 square meters. The construction was completed by the General Hospital of Ningxia Medical University. After completion, it will mainly carry out the application of clinical gene detection technology for tumor, monogenic genetic disease, cardiovascular and infectious diseases, individualized medical molecular diagnostic project research and development, reagent development and industrial application and promotion. The construction of the project will complete the genetic screening of hereditary diseases such as hereditary deafness and Down's syndrome in Ningxia, benefiting 30 million people, and is expected to achieve clinical diagnosis of 150,000 person/year.